Audit on herbal study protocols reviewed by an Ethics Review Committee of a Western Medical Institution Wanigatunge CA, Warnacula G, Prathapan S Ethics.

Slides:



Advertisements
Similar presentations
Management of Drug Formulary Dimitry Gotlinsky Western University Managed Care Clerkship ProPharma Pharmaceutical Consultants, Inc. 06/16/06.
Advertisements

Medication Management
Presentation of BE data in a product dossier Drs. Jan Welink Training workshop: Training of BE assessors, Kiev, October 2009.
Regulatory Clinical Trials Clinical Trials. Clinical Trials Definition: research studies to find ways to improve health Definition: research studies to.
Single-Patient Use of Investigational Drugs and Biologic Products for Treating Cancer Grant Williams, M.D. Medical Team Leader DODP/CDER/FDA.
Phase O Trials: Ethical Considerations Holly Taylor, PhD, MPH Department of Health Policy and Management Bloomberg School of Public Health Berman Institute.
Adapted from ISEF webpage Society for Science and the Public “Roles and Responsibilities of students and adults” Roles and Responsibilities of students.
Adequacy of Ethical Review and Informed Consent Documents in Investigations Submitted For Funding To The Eastern Mediterranean Region of the World Health.
Criteria for the selection non-health policies, programs and projects to which undergo HIA in Catalonia Anna Mompart Pilar Brugulat Vicenç Martínez Núria.
Clinical Trials Medical Interventions
Turning Questions into Trials: Innovation in Surgical Oncology Jennifer E. Rosen MD FACS Assistant Professor of Surgery and Molecular Medicine Boston University.
Columbia University IRB IRB 101 September 21, 2005 George Gasparis, Executive Director, CU IRB Asst. V.P. and Sr. Asst. Dean for Research Ethics.
Module 2 Sealy Center on Aging What kinds of scholarly products can I produce?
Clinical Trials of Traditional Herbal Medicines In India Y.K.Gupta Professor & Head, Department of Pharmacology, All India Institute of Medical Sciences,
Clinical Pharmacy’s Role in Research Trials Sheree Miller Pharm.D. Investigational Drug Service University of Washington Medical Center.
What is a Systematic review?. Systematic review  Combination of the best research projects in a specific area Selecting Identifying Synthesizing  Health.
Good Clinical Practice GCP
Their contribution to knowledge Morag Heirs. Research Fellow Centre for Reviews and Dissemination University of York PhD student (NIHR funded) Health.
Continuing Review VA Requirements Kevin L. Nellis, M.S., M.T. (A.S.C.P.) Program Analyst Program for Research Integrity Development and Education (PRIDE)
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
Yesterday, today, and tomorrow
A S Nanivadekar Introduction to GCP. A S Nanivadekar Outline Definition and scope Definition and scope Purpose of clinical research Purpose of clinical.
Retha Britz Copyright 2013 All rights reserved for this presentation 1 Establishment and functioning of a REC Retha Britz.
Institutional Review Board (IRB) Human Subject Dr. John N. Austin, Director and Ms. Renee S. Jones, Associate Director Delaware State University Office.
Jennifer Orwa, PhD, OGW Chief Research Officer, Kenya Medical Research Institute, Center for Traditional Medicine and Drug Research Presentation at the.
CLINICAL TRIALS – PHASE III. What are phase III trials  Confirmatory phase (Therapeutic confirmatory trial)  Trials are done to obtain sufficient evidence.
SARC: Participation and Protocol / Concept Review Robert Maki, MD PhD Memorial Sloan-Kettering Cancer Center.
CLINICAL TRIALS IN NEW DRUG DEVELOPMENT Michael A Ross,M.D. President CPL Inc.
Background Information Audience Response Systems (ARS) are a technology used in classrooms that consist of an input device controlled by the learner, a.
بسم الله الرحمن الرحيم جامعة أم درمان الإسلامية كلية الطب و العلوم الصحية - قسم طب المجتمع مساق البحث العلمي / الدفعة 21 Basics of Clinical Trials.
Copyright, 1996 © Dale Carnegie & Associates, Inc. CLINICAL TRIALS AND HUMAN SUBJECT PROTECTION: A PLAINTIFF’S PERSPECTIVE ALAN MILSTEIN SHERMAN SILVERSTEIN.
Understanding Clinical Trials – Part 2 Georgianne Arnold, MD Professor of Pediatrics University of Pittsburgh Medical Center Pittsburgh Children’s Hospital.
HA Central Register of Clinical Research 1 Dec 04 HA REC.
Informed Consent Issues in Research in Clinical Trial Unit, Universiti Sains Malaysia (USM), Malaysia Shaiful Bahari Ismail, Nik Hazlina Nik Hussain, Wan.
0 Ethics Lecture Research. ACADEMY OF OPHTHALMOLOGY Disclosures  The speaker has no financial interest in the subject matter of this.
Improving Process and Outcomes of Ethics Review at Faculty of Nursing, Chiang Mai University Anusra Thaprom, MBA Chawapornpan Chanprasit, PhD Suthisa Lamchang,
Antibiotic utilization in general medical units in a tertiary care institution Fernando GVMC, Ratnasekera IU, Perera MSD, Wanigatunge CA.
Quality Metrics of Performance of Research Ethics Committees Cristina E. Torres, PhD FERCAP Coordinator.
GCP (GOOD CLINICAL PRACTISE)
Responsibilities of Sponsor, Investigator and Monitor
Good Clinical Practice (GCP) and Monitoring Practices
CLINICAL TRIALS.
Introduction Review and proper registration of Human Gene Transfer protocols is very complex. A protocol goes through rigorous review by multiple Committees.
A capacity building programme for patient representatives
Responsibilities of Sponsor, Investigator and Monitor
Animals and Plants Complete GM Risk Assessment Form
Why participate in Accreditation?
Sign critical appraisal course: exercise 1
© 2010 Jones and Bartlett Publishers, LLC
© 2010 Jones and Bartlett Publishers, LLC
Within Trial Decisions: Unblinding and Termination
Leigh E. Tenkku, PhD, MPH Department of Family and Community Medicine
Clinical Trials Medical Interventions
Writing the research protocol
Evidence-Based Practice I: Definition – What is it?
Bozeman Health Clinical Research
Reading Research Papers-A Basic Guide to Critical Analysis
Ethical Principles of Research
Key Question WHY USE A NON-TRADITIONAL RCT DESIGN?
Khine Zaw Oo Defence Services Medical Research Centre Myanmar
DAY 2 Single-Case Design Drug Intervention Research Tom Kratochwill
Tim Auton, Astellas September 2014
IND Review Process Seoul National University
Human Gene Therapy Institutional Review Procedures
Title Presenting Author & Affiliation Co-Authors
Realizing effective health technology assessment for the SA healthcare environment Praneet Valodia The BHF Southern African Conference July’07.
Research, Experimentation, & Clinical Trials
Patient information sheet & Principles of Good Clinical Practice
DAY 2 Single-Case Design Drug Intervention Research Tom Kratochwill
Good clinical practice
Presentation transcript:

Audit on herbal study protocols reviewed by an Ethics Review Committee of a Western Medical Institution Wanigatunge CA, Warnacula G, Prathapan S Ethics Review Committee, Faculty of Medical Sciences University of Sri Jayewardenepura, Sri Lanka

Introduction Sri Lanka’s health system consists of Western and complementary and alternative medical (CAM) care systems 24/11/201515th FERCAP Annual Conference2

24/11/201515th FERCAP Annual Conference3 Veda Sala – Ancient Hospital Complex, Mihintale 9 th century AD

24/11/201515th FERCAP Annual Conference4 Medicinal trough Mortars and pestles

24/11/201515th FERCAP Annual Conference5

Introduction Exist side-by-side Good acceptance of both by the people CAM system is not evidence based in most instances 24/11/201515th FERCAP Annual Conference6

Introduction Increase in research based on CAM products in recent past Most of these protocols submitted to ERCs of medical schools of the Western medical system 24/11/201515th FERCAP Annual Conference7

Introduction Reviewing such protocols which are planned based on a different health care system is challenging Two systems have different philosophies and practices CAM therapies are often not about single drugs, herbs or limited combinations alone are based on a package of treatment - massage, diet, plus some herbs 24/11/201515th FERCAP Annual Conference8

Introduction Western system is not well designed to handle a multiplicity of interventions Members of ERCs are mostly with a western medical training This leads to the problems when evaluating protocols involving CAM procedures 24/11/201515th FERCAP Annual Conference9

Introduction ERC FMS USJ is 1/4 ERCs in Sri Lanka that has SIDECR recognition 1/8 ERCs that can approve phase 2/3 clinical trials in Sri Lanka One of the very few ERCs that review protocols pertaining to CAM and herbal studies 24/11/201515th FERCAP Annual Conference10

Objectives Audit the CAM protocols reviewed by ERC, Faculty of Medical Sciences, University of Sri Jayewardenepura (FMS, USJ) To determine the time taken from time of submission to final decision To determine the causes for delays in approval 24/11/201515th FERCAP Annual Conference11

Method CAM protocols were identified from the data base for the period of 3 years Data extraction form used to extract data Data analysed to find reasons for delays in ERC approval 24/11/201515th FERCAP Annual Conference12

Results Total of 11 protocols from /11/201515th FERCAP Annual Conference13

Results PI profile 7 – non medical basic degree 4 – medical degree – traditional system Types of studies 5 human – clinical trials 6 animal Average time for approval from the time of submission – 93.8 days (77.5 – days) Stop clock delay – 42.1 days (22.5 – 73 days) 24/11/201515th FERCAP Annual Conference14

Results Reasons for returning protocol to PI Issues in methodology - 9 (81.8%) Inadequate literature review -7 (63.6%) Inadequate information sheets and consent forms -6 (54.5%) Issues pertaining to fair subject selection – 4 (36.4%) 24/11/201515th FERCAP Annual Conference15

Results Reasons for returning protocol to PI Issues with study title - 2/11 (18.1%) Specific/General objectives not clearly stated -3/11 (27.3%) Issues with inclusion/ exclusion criteria - 2/11 (18.1%) Administrative issues - 6 (54.5%) 24/11/201515th FERCAP Annual Conference16

Analysis of protocols by the year 24/11/201515th FERCAP Annual Conference17

Conclusions There are deficiencies in the knowledge of PIs on How to write a proper protocol – literature review, methodology Ethical aspects of research and how to address these How to write an informed consent form properly Most problems are in methodology and risk benefit assessment ICFs and fair subject selection had improved over time 24/11/201515th FERCAP Annual Conference18

Recommendations Education of investigators on how protocols should be written properly how to identify ethical issues and what should be done to address them how to do a proper risk benefit assessment 24/11/201515th FERCAP Annual Conference19

24/11/201515th FERCAP Annual Conference20